Hansa Biopharma Partners with Cradle to Advance AI-Driven Protein Design and Engineering
<p>Hansa is deploying Cradle's end-to-end platform to develop novel immunomodulatory therapies in autoimmune disease. AMSTERDAM, Oct. 1, 2026 /PRNewswire/ -- Hansa Biopharma AB (Nasdaq Stockholm: HNSA), a pioneer in treatments for rare IgG related immunologic conditions, today announced a...</p>
Read original article ↗
Related Articles
NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in AI-first busines
Finland investigates suspected break-ins at several MPs homes, authorities say
All members of parliament had been told to remain vigilant, report observations and file police complaints if necessary.
Zetexa schließt ein Jahr nach dem Sieg in Barcelona eine Reihe großer europäischer Geschäfte ab
BARCELONA, Spanien, DUBAI, Vereinigte Arabische Emirate, und LONDON, 1. Oktober 2026 /PRNewswire/ -- Zwölf Monate nach d
Living Proof Gives Its Cult-Favorite Dry Shampoo the Scent of the Season: Frosted Fig
The limited-edition launch brings one of beauty's breakout scent notes to Advanced Clean Dry Shampoo, giving consumers a